SO
IMVT icon

STRS Ohio’s Immunovant IMVT Stock Holding History

STRS Ohio’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,600
Closed -$27.3K – 2249
2025
Q1 		$27.3K Hold
1,600
– – ﹤0.01% 1828
2024
Q4 		$39.6K Sell
1,600
-2,400
-60% -$68.1K ﹤0.01% 1753
2024
Q3 		$114K Sell
4,000
-13,500
-77% -$398K ﹤0.01% 1683
2024
Q2 		$462K Buy
17,500
+1,800
+11% +$51.2K ﹤0.01% 1294
2024
Q1 		$507K Sell
15,700
-2,500
-14% -$91.2K ﹤0.01% 1251
2023
Q4 		$766K Sell
18,200
-15,500
-46% -$570K ﹤0.01% 1013
2023
Q3 		$1.29M Sell
33,700
-2,400
-7% -$54.2K 0.01% 795
2023
Q2 		$684K Sell
36,100
-1,700
-4% -$31.7K ﹤0.01% 1104
2023
Q1 		$586K Buy
37,800
+1,800
+5% +$31.2K ﹤0.01% 1205
2022
Q4 		$639K Buy
36,000
+8,900
+33% +$112K ﹤0.01% 1162
2022
Q3 		$151K Hold
27,100
– – ﹤0.01% 1677
2022
Q2 		$105K Hold
27,100
– – ﹤0.01% 1760
2022
Q1 		$149K Hold
27,100
– – ﹤0.01% 1770
2021
Q4 		$230K Buy
27,100
+18,900
+230% +$156K ﹤0.01% 1698
2021
Q3 		$71K Buy
+8,200
New +$74K ﹤0.01% 1999
2021
Q1 		– Sell
-9,100
Closed -$420K – 2222
2020
Q4 		$420K Buy
9,100
+400
+5% +$18.5K ﹤0.01% 1545
2020
Q3 		$306K Buy
8,700
+3,800
+78% +$114K ﹤0.01% 1559
2020
Q2 		$119K Buy
+4,900
New +$105K ﹤0.01% 1753

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

STRS Ohio's IMVT Position: Q2 2025 in Review

STRS Ohio sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 1,600 shares — an estimated $27.3K sold.

STRS Ohio first reported a position in IMVT in Q2 2020 and held it in 18 quarters. The position peaked at $1.29M in Q3 2023. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • STRS Ohio reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 1,600 Immunovant shares in Q2 2025, an estimated $27.3K.
  • STRS Ohio first reported a position in Immunovant in Q2 2020 and held it in 18 quarters.
  • STRS Ohio's Immunovant position peaked at $1.29M in Q3 2023.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.